Associated Papers
Impacts of pathogenic mutations on the structures of the CHCHD10 monomer: An AlphaFold3 study linked to the generation of conformational ensembles.
Akkum FI et al.
International Journal of Biological Macromolecules, 2025
Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia.
Xu T et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2024
Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2020
Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis.
Keith JL et al.
Neurology. Genetics, 2020
A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS.
Lehmer C et al.
Embo Molecular Medicine, 2018
Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.
Zhou Q et al.
Molecular Neurobiology, 2017
CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China.
Shen S et al.
Neurobiology of Aging, 2017
Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.
Bannwarth S et al.
Brain : a Journal of Neurology, 2016
High prevalence of CHCHD10 mutation in patients with frontotemporal dementia from China.
Jiao B et al.
Brain : a Journal of Neurology, 2016
Select a paper to view details